Aran Research & Development (1982) (XTAE:ARAN) Shares Outstanding (EOP): 4.5 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTAE:ARAN Aran Research & Development (1982) Ltd XTAE:ARAN
78 GF Score
Price ₪39.78
GF Value ₪37.11
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Aran Research & Development (1982) Shares Outstanding (EOP)?

Aran Research & Development (1982) XTAE:ARAN +1.20% 78 Shares Outstanding (EOP) is 4.5 Mil as of Dec. 2025. GuruFocus rates XTAE:ARAN with a GF Score™ of 78/100 and a GF Value™ of ₪37.11 (Fairly Valued). The stock has 2 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Aran Research & Development (1982)'s shares outstanding for the quarter that ended in Dec. 2025 was 4.5 Mil.

Aran Research & Development (1982)'s quarterly shares outstanding stayed the same from Jun. 2025 (4.5 Mil) to Dec. 2025 (4.5 Mil).

Aran Research & Development (1982)'s annual shares outstanding declined from Dec. 2024 (4.9 Mil) to Dec. 2025 (4.5 Mil). It means Aran Research & Development (1982) bought back shares from Dec. 2024 to Dec. 2025 .


Aran Research & Development (1982)  (XTAE:ARAN) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Aran Research & Development (1982) Shares Outstanding (EOP) Related Terms


Aran Research & Development (1982) Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for Aran Research & Development (1982)'s Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aran Research & Development (1982) Shares Outstanding (EOP) Chart

Aran Research & Development (1982) Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.89 4.89 4.89 4.89 4.52

Aran Research & Development (1982) Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.89 4.89 4.89 4.52 4.52

XTAE:ARAN vs MMM, HON: Shares Outstanding (EOP) Comparison

For the Conglomerates subindustry, Aran Research & Development (1982)'s Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aran Research & Development (1982) Shares Outstanding (EOP) vs Conglomerates Industry

For the Conglomerates industry and Industrials sector, Aran Research & Development (1982)'s Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Aran Research & Development (1982)'s Shares Outstanding (EOP) falls into.


XTAE:ARAN
78GF Score
Aran Research & Development (1982) Ltd XTAE:ARAN
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aran Research & Development (1982) Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 4.5 Mil mean?
Aran Research & Development (1982) (XTAE:ARAN) has a Shares Outstanding (EOP) of 4.5 Mil as of Dec. 2025. The total shares a company has outstanding, at period-end. View historical data on Aran Research & Development (1982) and its competitors.
Is Aran Research & Development (1982)'s Shares Outstanding (EOP) too high?
Aran Research & Development (1982)'s current Shares Outstanding (EOP) is 4.5 Mil. Overall, Aran Research & Development (1982) has a GF Score™ of 78/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Aran Research & Development (1982)'s Shares Outstanding (EOP) compare to MMM and HON?
Aran Research & Development (1982)'s Shares Outstanding (EOP) of 4.5 Mil can be compared against companies in the Conglomerates industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Conglomerates company?
A good Shares Outstanding (EOP) depends on the Conglomerates industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Aran Research & Development (1982) and its competitors. Aran Research & Development (1982)'s current Shares Outstanding (EOP) is 4.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aran Research & Development (1982) stock overvalued right now?
Based on GuruFocus' analysis, Aran Research & Development (1982) (XTAE:ARAN) is currently considered Fairly Valued. The stock's GF Value™ is ₪37.11, compared to a current price of ₪39.78 — trading 7.2% above its estimated fair value. The current Shares Outstanding (EOP) is 4.5 Mil. Aran Research & Development (1982)'s overall GF Score™ is 78/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Aran Research & Development (1982) (XTAE:ARAN), the current Shares Outstanding (EOP) is 4.5 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aran Research & Development (1982) (XTAE:ARAN) Overvalued in 2026?

Based on GuruFocus' analysis, Aran Research & Development (1982) stock appears to be overvalued. The current stock price of ₪39.78 is trading 7.2% above its estimated GF Value™ of ₪37.11. GuruFocus considers Aran Research & Development (1982) to be Fairly Valued.

Key valuation signals for XTAE:ARAN:

  • Shares Outstanding (EOP): 4.5 Mil
  • GF Value™: ₪37.11 vs. price of ₪39.78 (7.2% above fair value)
  • GF Score™: 78/100 with 2 warning signs

No single metric tells the full story. See the XTAE:ARAN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Aran Research & Development (1982) Business Description

Address 43 HaEshel Street, P.O.B 3067, Caesarea Business Park, Tel Aviv, ISR, 3088900
Aran Research & Development (1982) Ltd is a product design and development company. It also manufactures equipment for the plastics industry. It develops & supplies products including medical devices, water, defense & HLS, consumer & industrial and injection molds. It also has medical startups which focuses on Cardiovascular, Laparoscopy and Gastrointestinal endoscopy.
78GF Score

Get the complete analysis for XTAE:ARAN

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₪39.78
Price
₪37.11
GF Value